Business Wire

Quanterix Announces FDA 510(k) Submission for a Multi-Analyte Algorithmic Blood Test for ...

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced it has ...
Yahoo Finance

Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit ...

CHICAGO, January 27, 2026--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced results from a new study ...
Morningstar

Quanterix Announces FDA 510(k) Submission for a Multi-Analyte Algorithmic Blood Test for ...

Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced it has submitted a 510(k) premarket ...